Search Results (7)
Click the Why column to see why an item matched the search.

MatchTypeWhy
Preclinical efficacy of MEK inhibition in Nras-mutant AML.Academic Article Why?
Protein kinase Cd is a therapeutic target in malignant melanoma with NRAS mutation.Academic Article Why?
Molecular determinants of NRAS oncogene dependency in melanomaGrant Why?
Singh, AnuragPerson Why?
Faller, DouglasPerson Why?
Huang, TanniePerson Why?
Cui, RutaoPerson Why?
First Prev Page of 1 Next Last Per PageĀ 
Most Viewed
Search Criteria
  • NRAS
Filter by Type